”They did a CAT scan. Then we went in for the results. That’s when the doctor just said, ‘You have stage four mesothelioma, John.’ We were shocked.” Peritoneal Mesothelioma Peritoneal mesotheliomadevelops in the peritoneum, or the lining of the abdomen. ...
Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment 恶性肿瘤综合治疗早期诊断预后膜矿物纤维遗传因素一次曝光Malignant pleural mesothelioma(MPM)is the most common primary malignancy of the pleura.The occurrence of malignant mesothelioma is typically related to ...
Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma. Background: malignant peritoneal mesothelioma (MPM) is a rare peritoneal mesothelial neoplasm. Ki67 and BCL2 are established prognostic markers in several ... Pillai,Krishna,Pourgholami,... - 《American Journal of Cancer Research》 ...
This disease is difficult to detect in its early stages, and treatments for late-stage lung cancer provide a poor prognosis. Survival rates vary depending on the cancer type. According to the American Cancer Society, over five years the average survival rate is 24% across all stages of non-s...
Sarcomatoid carcinoma of the pancreas(SCP)is a very rare pathological type of carcinoma that usually has a poor prognosis.Its pathogenesis has not been elucidated.We herein report a case of an early-stage SCP involving successful treatment and a good prognosis.The patient was a 48-year-old Chin...
Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.Am J Gastroenterol 1991; 86: 1784–1788. PubMed CAS Google Scholar Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, ...
CA-125 serves many purposes such as a valuable means for diagnosis, prognosis, and to monitor post-treatment of following diseases ovarian cancer [135], breast cancer [136], Non-Hodgkin’s Lymphoma (NHL) [137], gastrointestinal carcinoma lymphoma [138], malignant mesothelioma B-cell lymphoma [...
Malignant pleural mesothelioma (MPM) is an aggressive disease with poor prognosis and the current treatment for early-stage MPM is based on a multimodality therapy regimen involving platinum-based chemotherapy preceding or following surgery. To enhance the cytoreductive role of surgery, some peri- or ...
Using serum samples from healthy controls (NC), diabetic patients (DM), early-medium stage DN (DN-EM), and late-stage DN (DN-L), researchers employed quantitative proteomics and Mfuzz clustering analysis revealed 15 proteins showing increased expression during DN progression, hinting at their ...
Patients with TLR3-positive immune infiltrating cells, but not tumor cells showed a worse prognosis compared with all other patients. The majority of TLR3-expressing immune cells resulted to be macrophages and TLR3 expression associates with PD-1 expression. TLR3 has an opposite prognostic ...